Increased serum concentrations of interleukin-1β in patients with coronary artery disease

Heart

Volumn 76, Issue 1, 1996, Pages 24-28

  Hasdai, D ^a   Scheinowitz, M ^a,c   Leibovitz, E ^a   Sclarovsky, S ^a   Eldar, M ^a   Barak, V ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

atherosclerosis; inflammation; interleukin 1

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL;

EID: 0029792534     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.1.24     Document Type: Article

References (42)

1. Dinarello CA. Interleukin-1. Rev Infect Dis 1984;6:51-95.
2. Gearing JH, Johnstone AP, Thorpe R. Production and assay of the interleukins. J Immunol Methods 1985;83: 1-27.
3. Meager A, Leung H, Wolley J. Assays for tumor necrosis factor and related cytokines. J Immunol Methods 1989; 116:1-17.
4. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
5. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992;86:III47-III52.
6. Brody JI, Pickering NJ, Capuzzi DM, Fink GB, Can CA, Gomez F. Interleukin-1α as a factor in occlusive vascular disease. Am J Clin Pathol 1992;97:8-13.
7. Moyer CF, Sajuthi D, Tulli H, Williams JK. Synthesis of II-1 alpha and II-1 beta by arterial cells in atherosclerosis. Am J Pathol 1991;138:951-60.
8. Wang A, Doyle M, Mark D. Quantification of mRNA using the polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:9717-21.
9. Clausell N, Molossi S, Sett S, Rabinoviteh M. In vivo blockade of tumor-necrosis factor-alpha in cholesterolfed rabbits after cardiac transplantation inhibits acute coronary artery neointimal formation. Circulation 1994; 89:2768-79.
10. Claussel N, Rabinovitch M. Upregulation of fibronectin synthesis by interleukin-1β in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets. J Clin Invest 1993;92:1850-8.
11. Clausell N, Molossi S, Rabinovitch M. Increased interleukin-1β and fibronectin expression are early features of the development of the post-cardiac transplant coronary arteriopathy in piglets. Am J Pathol 1993;142:1772-86.
12. Tanaka H, Sukhova GK, Libby P. Interaction of the allogenic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb 1994;14:734-45.
13. Calderon TM, Factor SM, Hatcher VH, Berliner JA, Berman JW. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Lab Invest 1994;70:834-49.
14. Leszczynski D, Josephs MD, Foegh ML. IL-1 beta-stimulated leucocyte-endothelial adhesion is regulated, in part, by the cyclic-GMP-dependent signal transduction pathway. Scand J Immunol 1994;39:551-6.
15. Libby P, Ordovas JM, Birinyi LK, Auger KR, Dinarello CA. Induction of interleukin-1 expression in human vascular smooth muscle cells. J Clin Invest 1986;78:1432-8.
16. Libby P, Ordovas JM, Auger KR, Robbins H, Birinyi LK, Dinarello CA. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 1986;124:179-86.
17. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Giimbrone MA Jr. Interleukin 1 induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-23.
18. Lopes-Virella MF. Interactions between bacterial liposaccharides and serum lipoproteins and their possible role in coronary artery disease, Eur Heart J 1993;14 suppl K: 118-24.
19. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin-1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 1989;86:6753-7.
20. Chung MK, Gulick TS, Rotondo RF, Schreiner GF, Lange LG. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res 1990;67:753-63.
21. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72: 561-6.
22. Latini R, Bianchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, et al. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol 1994;3:1-6.
23. Entman ML, Michael L, Rossen RD, Dreyer WJ, Anderson DC, Taylor AA, et al. Inflammation in the course of early myocardial ischaemia. FASEB J 1991;5: 2529-37.
24. Ross R. The pathogenesis of atherosclerosis an update. N Engl J Med 1986;314:488-44.
25. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation 1985;71:709-16.
26. Sato T, Takebayashi S, Kohchi K. Increased subendothelial infiltration of the coronary arteries with monocytes macrophages in patients with unstable angina: histological data on 14 autopsied patients. Atherosclerosis 1987;68: 191-7.
27. Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina, Circulation 1992;86:790-7.
28. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
29. Berk BC, Weintraub VTS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-72.
30. de Beer FC, Hind CRK, Fox KM, Allan RM, Masen A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982;47:239-43.
31. Liuzzo G, Pepys MB, Maseri A. C-reactive protein and serum amyloid A protein in unstable angina. N Engl J Med 1995;332:344-400.
32. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part I. N Engl J Med 1991;326: 242-50.
33. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part II N Engl J Med 1991;326:310-8.
34. Ishizaku H, Okumura K, Yamabe H, Tsuchiya T, Yasue H. Endothelium-derived nitric oxide as a mediator of acetylcholine-induced coronary vasodilation in dogs J Cardiovasc Pharmacol 1991;18:665-9.
35. Tsujino M, Hirata Y, Imai T, Kanno K, Eguchi S, Ito H, et al. Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes. Circulation 1994;90: 375-83.
36. Cunha FQ, Assreuy J, Moss DW, Rees D, Leal LM, Moncada S, et al. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-α and II-I-β. Immunology 1994;81: 211-5.
37. Szabo C, Wu CC, Gross SS, Thiemermann C, Vane JR. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur J Pharmacol 1993, 250:157-60.
38. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, et al. Endothelial production of C-type nutriuretic peptide - evidence for cytokine regulation (abstract). Circulation 1993;88:I-621.
39. Alexander HR, Doherty GM, Venzon DJ, Merino MJ, Fraker DL, Norton JA. Recombinant interleukin-1 receptor antagonist (IL-Ira): effective therapy against gram negative sepsis in rats. Surgery 1992;112:188-93.
40. Hamsten A. Hemostatic function and coronary artery disease. N Engl J Med 1995;332:677-8.
41. Brown JM, White CW, Terada LS, Grosso MA, Shanley PF, Mulvin DW. Interleukin 1 pretreatment decreases ischaemia/reperfusion injury. Proc Natl Acad Sci USA 1990;87:5026-30.
42. Maulik N, Engelman RM, Wei Z, Lu D, Rousou JA, Das DK. Interleukin-1 alpha preconditioning reduces myocardial ischaemia reperfusion injury, Circulation 1993; 88:II387-94.